191 related articles for article (PubMed ID: 8438616)
1. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers.
Li A; Kärnell A; Huan PT; Cam PD; Minh NB; Trâm LN; Quy NP; Trach DD; Karlsson K; Lindberg G
Vaccine; 1993; 11(2):180-9. PubMed ID: 8438616
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.
Li A; Pál T; Forsum U; Lindberg AA
Vaccine; 1992; 10(6):395-404. PubMed ID: 1598788
[TBL] [Abstract][Full Text] [Related]
3. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124.
Li A; Cam PD; Islam D; Minh NB; Huan PT; Rong ZC; Karlsson K; Lindberg G; Lindberg AA
J Infect; 1994 Jan; 28(1):11-23. PubMed ID: 8163828
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.
Kärnell A; Li A; Zhao CR; Karlsson K; Nguyen BM; Lindberg AA
Vaccine; 1995 Jan; 13(1):88-99. PubMed ID: 7762285
[TBL] [Abstract][Full Text] [Related]
5. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates.
Simon JK; Wahid R; Maciel M; Picking WL; Kotloff KL; Levine MM; Sztein MB
Vaccine; 2009 Jan; 27(4):565-72. PubMed ID: 19022324
[TBL] [Abstract][Full Text] [Related]
7. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
9. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
[TBL] [Abstract][Full Text] [Related]
10. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies.
Kärnell A; Stocker BA; Katakura S; Reinholt FP; Lindberg AA
Vaccine; 1992; 10(6):389-94. PubMed ID: 1598787
[TBL] [Abstract][Full Text] [Related]
11. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
Kotloff KL; Noriega F; Losonsky GA; Sztein MB; Wasserman SS; Nataro JP; Levine MM
Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.
Mallett CP; VanDeVerg L; Collins HH; Hale TL
Vaccine; 1993; 11(2):190-6. PubMed ID: 8438617
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.
Chakraborty S; Harro C; DeNearing B; Bream J; Bauers N; Dally L; Flores J; Van de Verg L; Sack DA; Walker R
Clin Vaccine Immunol; 2016 Apr; 23(4):315-25. PubMed ID: 26865592
[TBL] [Abstract][Full Text] [Related]
14. Development of an auxotrophic oral live Shigella flexneri vaccine.
Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
16. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
17. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.
Simon JK; Maciel M; Weld ED; Wahid R; Pasetti MF; Picking WL; Kotloff KL; Levine MM; Sztein MB
Clin Immunol; 2011 May; 139(2):185-92. PubMed ID: 21388888
[TBL] [Abstract][Full Text] [Related]
18. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 years.
Dentchev V; Marinova S; Vassilev T; Bratoyeva M; Linde K
Vaccine; 1990 Feb; 8(1):30-4. PubMed ID: 2180231
[TBL] [Abstract][Full Text] [Related]
19. Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.
Taylor DN; Phillip DF; Zapor M; Trofa A; Van de Verg L; Hartman A; Bendiuk N; Newland JW; Formal SB; Sadoff JC
Vaccine; 1994 May; 12(6):565-8. PubMed ID: 8036831
[TBL] [Abstract][Full Text] [Related]
20. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]